| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5845026 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2012 | 9 Pages |
Abstract
⺠Psychotropics are widely used in treating Parkinson's disease (PD). ⺠Initial evidence indicates these psychotropics can affect PD risk-gene transcription. ⺠Further study of PD risk-gene transcription in PD clinical models is warranted. ⺠Studies should focus on psychotropic-related modification of PD risk and progression.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Edward C. Lauterbach,